Home Infusion Therapy Market is Expected to Reach US$ 59.7 Billion by 2028

IMARC Group, a leading market research company, has recently releases report titled "Home Infusion Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The study provides a detailed analysis of the industry, including the global home infusion therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the home infusion therapy market?

The global home infusion therapy market size reached US$ 40.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 59.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.

What is home infusion therapy?

Home infusion therapy refers to the administration of drugs or biologicals intravenously or subcutaneously to an individual at home. It is cost-saving, safe, comfortable, and flexible as compared to hospital treatment. It is utilized when the patient cannot be treated effectively by oral medications. It assists in preventing various diseases, such as cancers, congestive heart failure, Crohn's Disease, hemophilia, immune deficiencies, and multiple sclerosis. Besides this, home infusion therapy aids in reducing long stays in hospitals and limiting expensive hospital bills.            

Request for a free sample copy of this report: https://www.imarcgroup.com/home-infusion-therapy-market/requestsample

What are the growth prospects and trends in the home infusion therapy industry?

At present, the rising prevalence of chronic diseases, such as diabetes, kidney problems, arthritis, and heart diseases among the masses, represents one of the primary factors bolstering the growth of the market. Besides this, the growing incidences of hospital-acquired infections (HAIs) due to longer hospital stays are offering a positive market outlook. Apart from this, the increasing demand for home infusion therapy, as it is cost-effective, safe, and convenient for patients, is strengthening the growth of the market. Moreover, the development of smart infusion pumps to prevent dosing errors and enhance patient safety are offering lucrative growth opportunities to industry investors. Furthermore, the increasing demand for home infusion therapy due to the rising geriatric population is propelling the growth of the market.  

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

Infusion Pumps
Elastomeric
Electromechanical
Gravity
Others
Intravenous Sets
IV Cannulas
Needleless Connectors

Breakup by Application:

Anti-Infective
Endocrinology
Diabetes
Others
Hydration Therapy
Athletes
Others
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Who are the key players operating in the industry?

The report covers the major market players including:

Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company,
Eli Lilly and Company
Fresenius SE & Co. KGaA
ICU Medical Inc.
JMS Co. Ltd.
Nipro Corporation
Option Care Health Inc. (Walgreen Co.)
Smiths Group plc
Terumo Corporation

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4098&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.